BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28969003)

  • 21. Diagnostic accuracy of SATB2 in identifying primary and metastatic colorectal carcinoma: a comparative immunohistochemical study.
    Elnady MS; Eltatawy FA; Nosseir AG; Zamzam YA; El-Guindya DM
    Ecancermedicalscience; 2022; 16():1491. PubMed ID: 36819801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual Stain With SATB2 and CK20/Villin Is Useful to Distinguish Colorectal Carcinomas From Other Tumors.
    Li Z; Rock JB; Roth R; Lehman A; Marsh WL; Suarez A; Frankel WL
    Am J Clin Pathol; 2018 Feb; 149(3):241-246. PubMed ID: 29471325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
    McCluggage WG; Shah R; Connolly LE; McBride HA
    Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Progress in pulmonary enteric adenocarcinoma].
    Zuo Y; Bai H; Ying JM; Wang J
    Zhonghua Zhong Liu Za Zhi; 2022 Apr; 44(4):321-325. PubMed ID: 35448919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinicopathological and molecular features of pulmonary enteric adenocarcinoma].
    Gao G; Wang YZ; Zhang YP; Feng SE; Hou M; Xia QX
    Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):544-549. PubMed ID: 32486530
    [No Abstract]   [Full Text] [Related]  

  • 26. Thyroid transcription factor-1 expression in rectal adenocarcinoma metastatic to the lung.
    Takanashi Y; Kurachi K; Fujihiro M; Sekihara K; Torii K; Kawase A; Matsubayashi Y; Hayakawa T; Baba S; Sugimura H; Iwashita T; Funai K
    Respir Med Case Rep; 2023; 42():101812. PubMed ID: 36660070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of SATB2 in the differential diagnosis of intestinal-type mucinous tumors of the ovary: primary vs metastatic.
    Perez Montiel D; Arispe Angulo K; Cantú-de León D; Bornstein Quevedo L; Chanona Vilchis J; Herrera Montalvo L
    Ann Diagn Pathol; 2015 Aug; 19(4):249-52. PubMed ID: 26059401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small Bowel Adenocarcinomas Featuring Special AT-Rich Sequence-Binding Protein 2 (SATB2) Expression and a Colorectal Cancer-Like Immunophenotype: A Potential Diagnostic Pitfall.
    Neri G; Arpa G; Guerini C; Grillo F; Lenti MV; Giuffrida P; Furlan D; Sessa F; Quaquarini E; Viglio A; Ubezio C; Pasini A; Ferrero S; Sampietro G; Ardizzone S; Latella G; Mescoli C; Rugge M; Zingone F; Barresi V; Ciccocioppo R; Pedrazzoli P; Corazza GR; Luinetti O; Solcia E; Paulli M; Di Sabatino A; Vanoli A
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33228145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of Cdx2 in separating mucinous bronchioloalveolar adenocarcinoma of the lung from metastatic mucinous colorectal adenocarcinoma.
    Saad RS; Cho P; Silverman JF; Liu Y
    Am J Clin Pathol; 2004 Sep; 122(3):421-7. PubMed ID: 15362373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas.
    Magnusson K; de Wit M; Brennan DJ; Johnson LB; McGee SF; Lundberg E; Naicker K; Klinger R; Kampf C; Asplund A; Wester K; Gry M; Bjartell A; Gallagher WM; Rexhepaj E; Kilpinen S; Kallioniemi OP; Belt E; Goos J; Meijer G; Birgisson H; Glimelius B; Borrebaeck CA; Navani S; Uhlén M; O'Connor DP; Jirström K; Pontén F
    Am J Surg Pathol; 2011 Jul; 35(7):937-48. PubMed ID: 21677534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SATB2 Versus CDX2: A Battle Royale for Diagnostic Supremacy in Mucinous Tumors.
    Brettfeld SM; Ramos BD; Berry RS; Martin DR; Hanson JA
    Arch Pathol Lab Med; 2019 Sep; 143(9):1119-1125. PubMed ID: 30838879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary pulmonary adenocarcinoma with enteric differentiation resembling metastatic colorectal carcinoma: a report of the second case negative for cytokeratin 7.
    Hatanaka K; Tsuta K; Watanabe K; Sugino K; Uekusa T
    Pathol Res Pract; 2011 Mar; 207(3):188-91. PubMed ID: 20727680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic and epigenomic profiles distinguish pulmonary enteric adenocarcinoma from lung metastatic colorectal cancer.
    Zuo Y; Zhong J; Bai H; Xu B; Wang Z; Li W; Chen Y; Jin S; Wang S; Wang X; Wan R; Xu J; Fei K; Han J; Yang Z; Bao H; Shao Y; Ying J; Song Q; Duan J; Wang J
    EBioMedicine; 2022 Aug; 82():104165. PubMed ID: 35901658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung.
    Ye J; Findeis-Hosey JJ; Yang Q; McMahon LA; Yao JL; Li F; Xu H
    Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):313-7. PubMed ID: 21464700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cadherin-17 (CDH17) expression in human cancer: A tissue microarray study on 18,131 tumors.
    Jacobsen F; Pushpadevan R; Viehweger F; Freytag M; Schlichter R; Gorbokon N; Büscheck F; Luebke AM; Putri D; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Fraune C; Bernreuther C; Lebok P; Sauter G; Minner S; Steurer S; Simon R; Burandt E; Dum D; Lutz F; Marx AH; Krech T; Clauditz TS
    Pathol Res Pract; 2024 Apr; 256():155175. PubMed ID: 38452580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma.
    Kennedy MT; Jordan RC; Berean KW; Perez-Ordoñez B
    J Clin Pathol; 2004 Sep; 57(9):932-7. PubMed ID: 15333652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue-specific cadherin CDH17 is a useful marker of gastrointestinal adenocarcinomas with higher sensitivity than CDX2.
    Panarelli NC; Yantiss RK; Yeh MM; Liu Y; Chen YT
    Am J Clin Pathol; 2012 Aug; 138(2):211-22. PubMed ID: 22904132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and treatment of primary pulmonary enteric adenocarcinoma: Report of Six cases.
    Tu LF; Sheng LY; Zhou JY; Wang XF; Wang YH; Shen Q; Shen YH
    World J Clin Cases; 2021 Oct; 9(30):9236-9243. PubMed ID: 34786410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinctive features of immunostaining and mutational load in primary pulmonary enteric adenocarcinoma: implications for differential diagnosis and immunotherapy.
    Chen M; Liu P; Yan F; Xu S; Jiang Q; Pan J; He M; Shen P
    J Transl Med; 2018 Mar; 16(1):81. PubMed ID: 29587865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value of SATB2 immunostaining in the distinction between small intestinal and colorectal adenocarcinomas.
    Kim CJ; Baruch-Oren T; Lin F; Fan XS; Yang XJ; Wang HL
    J Clin Pathol; 2016 Dec; 69(12):1046-1050. PubMed ID: 27169755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.